Related references
Note: Only part of the references are listed.The incretin hormones glucagonlike peptide 1 and glucose-dependent insulinotropic polypeptide are neuroprotective in mouse models of Alzheimer's disease
Christian Hoelscher
ALZHEIMERS & DEMENTIA (2014)
Tau protein kinases: Involvement in Alzheimer's disease
Ludovic Martin et al.
AGEING RESEARCH REVIEWS (2013)
The neuroprotective effects of GLP-1: Possible treatments for cognitive deficits in individuals with mood disorders
Roger S. McIntyre et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
The development of effective biomarkers for Alzheimer's disease: a review
Mark S. Henry et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2013)
Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis
Kerry Hunter et al.
BMC NEUROSCIENCE (2012)
Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimers Disease
Suzanne M. de la Monte
Current Alzheimer Research (2012)
GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease
Chong Gao et al.
REVIEWS IN THE NEUROSCIENCES (2012)
Clarifying the Role of Incretin-Based Therapies in the Treatment of Type 2 Diabetes Mellitus
R. Keith Campbell
CLINICAL THERAPEUTICS (2011)
Current and Emerging Drug Treatment Options for Alzheimerʼs Disease
Nathan Herrmann et al.
DRUGS (2011)
A Common Pathogenic Mechanism Linking Type-2 Diabetes and Alzheimer's Disease: Evidence from Animal Models
Sun Ah Park
JOURNAL OF CLINICAL NEUROLOGY (2011)
Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes
Ying Liu et al.
JOURNAL OF PATHOLOGY (2011)
Mechanism-based population modelling for assessment of L-cell function based on total GLP-1 response following an oral glucose tolerance test
Jonas B. Moller et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2011)
Targeting Tau Protein in Alzheimer's Disease
Cheng-Xin Gong et al.
DRUGS & AGING (2010)
Phosphatidylinositol 3-Kinase (PI3K) Signaling via Glycogen Synthase Kinase-3 (Gsk-3) Regulates DNA Methylation of Imprinted Loci
Anthony P. Popkie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling
Aileen M. Moloney et al.
NEUROBIOLOGY OF AGING (2010)
Glucagon Like Peptide-1-Directed Human Embryonic Stem Cells Differentiation Into Insulin-Producing Cells Via Hedgehog, cAMP, and PI3K Pathways
Hongxiang Hui et al.
PANCREAS (2010)
Linking type 2 diabetes and Alzheimer's disease
Weiping Han et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease
Talib Abbas et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Evidence that Intestinal Glucagon-Like Peptide-1 Plays a Physiological Role in Satiety
Diana L. Williams et al.
ENDOCRINOLOGY (2009)
Risk of Incident Alzheimer's Disease in Diabetic Patients: A Systematic Review of Prospective Trials
Daniel Kopf et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease
Ying Liu et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system
Alison Hamilton et al.
NEUROREPORT (2009)
Defective Insulin Signaling Pathway and Increased Glycogen Synthase Kinase-3 Activity in the Brain of Diabetic Mice: Parallels With Alzheimer's Disease and Correction by Insulin
C. G. Jolivalt et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
Insulin resistance syndrome and Alzheimer's disease: Age- and obesity-related effects on memory, amyloid, and inflammation
S Craft
NEUROBIOLOGY OF AGING (2005)
Detection of β-endorphin in the cerebrospinal fluid after intrastriatal microinjection into the rat brain
M Hoistad et al.
BRAIN RESEARCH (2005)
Biphasic effects of stress upon GLUT8 glucose transporter expression and trafficking in the diabetic rat hippocampus
GG Piroli et al.
BRAIN RESEARCH (2004)
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
MJ During et al.
NATURE MEDICINE (2003)
Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4
T Perry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5
F Liu et al.
NEUROSCIENCE (2002)